ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,582, issued on July 8, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai).

"Aurora kinase inhibitors and uses thereof" was invented by Yuli Xie (Shanghai) and Houxing Fan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a type of novel pyridine compound and a preparation method and application thereof. Specifically, the invention relates to a compound of formula (1) and a preparation method thereof, and an application of the compound of formula (1) and pharmaceutically acceptable salts thereof as aurora kinase inhibitors in preparation of anti-tumor drugs."

The patent was filed on March 14, 2...